10
5
5
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
5/29/2026, 4:11 PM
Summary of Bill SRES 732
This is Senate Resolution 732 of the 119th Congress, introduced on May 14, 2026. The resolution expresses the Senate's support for recognizing over 25 years of evidence and numerous studies demonstrating the safety and efficacy of mifepristone. It calls for equitable, transparent laws and policies regarding access to time-sensitive medication abortion, based on peer-reviewed scientific evidence.
Read the Full Bill
Current Status of Bill SRES 732
Bill SRES 732 is currently in the status of Bill Introduced since May 14, 2026. Bill SRES 732 was introduced during Congress 119 and was introduced to the Senate on May 14, 2026. Bill SRES 732's most recent activity was Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310) as of May 14, 2026
Bipartisan Support of Bill SRES 732
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
46Democrat Cosponsors
44Republican Cosponsors
0Unaffiliated Cosponsors
2Policy Area and Potential Impact of Bill SRES 732
Primary Policy Focus
HealthAlternate Title(s) of Bill SRES 732
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Comments
Kole Gray
936
2 months ago
I don't agree with this bill. It's not fair to force people to accept something they don't believe in. It's important to consider all perspectives and not just push one agenda. It's not right to ignore the concerns of those who may be affected by this.
Sponsors and Cosponsors of SRES 732
Latest Bills
NIH IMPROVE Act
Bill HR 6238August 19, 2026
Continuing Appropriations and Extensions Act, 2027
Bill HR 6500August 18, 2026
Permitting Transparency and Accountability Act
Bill S 1735August 18, 2026
Chiricahua National Park Act
Bill S 3715August 18, 2026
To designate the Christiansted Bandstand at the Christiansted National Historic Site, St. Croix, Virgin Islands, as the "Peter G. Thurland, Sr., Bandstand".
Bill HR 8121August 18, 2026
Parents Opt-in Protection Act
Bill HR 4986August 18, 2026
College Transparency Act
Bill S 2511August 18, 2026
Ratepayer Protection Act
Bill HR 9340August 18, 2026
RISE Act
Bill S 3589August 14, 2026
Federal Building Threat Notification Act
Bill S 2542August 14, 2026
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Bill HRES 1285May 29, 2026